A researcher with ties to Seattle-based biotech company OncoSenX has received a $4.2 million grant from the Canadian Institutes of Health Research for work on a COVID-19 vaccine. John Lewis,… Read More
Story updated with comments from Scholz below. Seattle biotech startup OncoSenX has reeled in $3 million to advance its pipeline of therapeutics that aim to kill cancer cells based on… Read More